Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced NSCLC × Ipilimumab × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 84 Lung Neoplasms 31 Small Cell Lung Carcinoma 18 Melanoma 17 Mesothelioma 12 Neoplasms 11 Colorectal Neoplasms 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 7 Neoplasm Metastasis 7 Mesothelioma, Malignant 7 Carcinoma, Transitional Cell 7 Ovarian Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Liver Neoplasms 5 Endometrial Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Kidney Neoplasms 4 Brain Neoplasms 4 Carcinoma, Merkel Cell 3 Skin Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Lung Diseases 2 Head and Neck Neoplasms 2

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 famitinib 1 camrelizumab 1 aflutinib 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡